Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Chapple

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Urology|April 18, 2000
Muscarinic receptor antagonists in the treatment of overactive bladderC R Chapple
European Urology|March 29, 2001
Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practicesC R Chapple
European Urology|January 1, 1996
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experienceC R Chapple
European Urology|September 11, 1998
Medical therapy and quality of lifeC R Chapple
The Journal of Urology|March 9, 2021
Editorial CommentC R Chapple
BJU International|August 10, 2000
Urethral injuryC R Chapple
European Urology|November 24, 1999
BHP Disease Management. Introduction and concluding remarksC R Chapple
British Journal of Urology|February 1, 1994
The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasiaC R Chapple, D Smith
The Journal of Urology|November 1, 1993
The UroLume stent in the management of benign prostatic hyperplasiaE Milroy, C R Chapple
Current Opinion in Urology|March 22, 2000
Contemporary management of urethral trauma and the post-traumatic strictureC R Chapple, D Png
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Urology|April 18, 2000
Muscarinic receptor antagonists in the treatment of overactive bladderC R Chapple
European Urology|March 29, 2001
Introduction and conclusions. Improving the management of lower urinary tract symptoms in real life practicesC R Chapple
European Urology|January 1, 1996
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experienceC R Chapple
European Urology|September 11, 1998
Medical therapy and quality of lifeC R Chapple
The Journal of Urology|March 9, 2021
Editorial CommentC R Chapple
BJU International|August 10, 2000
Urethral injuryC R Chapple
European Urology|November 24, 1999
BHP Disease Management. Introduction and concluding remarksC R Chapple
British Journal of Urology|February 1, 1994
The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasiaC R Chapple, D Smith
The Journal of Urology|November 1, 1993
The UroLume stent in the management of benign prostatic hyperplasiaE Milroy, C R Chapple
Current Opinion in Urology|March 22, 2000
Contemporary management of urethral trauma and the post-traumatic strictureC R Chapple, D Png
Pageof 19